Silence Therapeutics Statistics
Total Valuation
SLNCF has a market cap or net worth of 313.64 million. The enterprise value is 243.70 million.
| Market Cap | 313.64M |
| Enterprise Value | 243.70M |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 141.70M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 24.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 373.82 |
| PB Ratio | 6.35 |
| P/TBV Ratio | 8.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.25 |
| EV / Sales | 290.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.71 |
Financial Position
The company has a current ratio of 9.83, with a Debt / Equity ratio of 0.00.
| Current Ratio | 9.83 |
| Quick Ratio | 8.82 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -92.56% and return on invested capital (ROIC) is -55.14%.
| Return on Equity (ROE) | -92.56% |
| Return on Assets (ROA) | -29.79% |
| Return on Invested Capital (ROIC) | -55.14% |
| Return on Capital Employed (ROCE) | -68.42% |
| Weighted Average Cost of Capital (WACC) | 12.58% |
| Revenue Per Employee | 9,534 |
| Profits Per Employee | -852,716 |
| Employee Count | 88 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SLNCF has paid 11,000 in taxes.
| Income Tax | 11,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.28% in the last 52 weeks. The beta is 1.52, so SLNCF's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | +9.28% |
| 50-Day Moving Average | 1.55 |
| 200-Day Moving Average | 4.74 |
| Relative Strength Index (RSI) | 39.78 |
| Average Volume (20 Days) | 954 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SLNCF had revenue of 839,000 and -75.04 million in losses. Loss per share was -1.61.
| Revenue | 839,000 |
| Gross Profit | 667,000 |
| Operating Income | -71.61M |
| Pretax Income | -75.03M |
| Net Income | -75.04M |
| EBITDA | -71.08M |
| EBIT | -71.61M |
| Loss Per Share | -1.61 |
Balance Sheet
The company has 70.08 million in cash and 136,000 in debt, with a net cash position of 69.94 million.
| Cash & Cash Equivalents | 70.08M |
| Total Debt | 136,000 |
| Net Cash | 69.94M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 49.40M |
| Book Value Per Share | 1.05 |
| Working Capital | 92.39M |
Cash Flow
In the last 12 months, operating cash flow was -65.57 million and capital expenditures -51,000, giving a free cash flow of -65.62 million.
| Operating Cash Flow | -65.57M |
| Capital Expenditures | -51,000 |
| Depreciation & Amortization | 523,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -65.62M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 79.50% |
| Operating Margin | -8,534.68% |
| Pretax Margin | -8,942.55% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLNCF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.35% |
| Shareholder Yield | -0.35% |
| Earnings Yield | -23.93% |
| FCF Yield | -20.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |